Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Anticipates Diovan Pricing Will Contribute To Near-Term Growth

This article was originally published in The Pink Sheet Daily

Executive Summary

Pending oral iron-chelating agent Exjade could be priced at a premium compared with current first-line therapy, Novartis says during its third quarter call Oct. 18.

You may also be interested in...



Novartis Exjade Clears FDA As First Oral Chelating Agent

Novartis receives broad indication for deferasirox for treatment of iron overload in patients over 2 years of age.

Novartis Exjade Clears FDA As First Oral Chelating Agent

Novartis receives broad indication for deferasirox for treatment of iron overload in patients over 2 years of age.

Novartis' Exjade Recommended For Approval Under Broader Indication

FDA's Blood Products Advisory Committee agreed that data for the oral chelating agent from primarily thalassemia patients may be extrapolated to transfusional hemosiderosis.

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel